Cargando…
Dual-target ligand discovery for Alzheimer’s disease: triphenylphosphoranylidene derivatives as inhibitors of acetylcholinesterase and β-amyloid aggregation
Alzheimer disease (AD) is one of the major neurodegenerative diseases that could not be prevented or completely cured and may lead to death. Here, we target AChE and β-amyloid proteins. Synthesising new triphenylphosphporanylidene derivatives based on the surveyed literature and testing their biolog...
Autores principales: | El-Hussieny, Marwa, Abd-El-Maksoud, Mansoura A., Soliman, Fouad M., Fouad, Marwa A., El-Ashrey, Mohamed K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879200/ https://www.ncbi.nlm.nih.gov/pubmed/36695002 http://dx.doi.org/10.1080/14756366.2023.2166040 |
Ejemplares similares
-
Novel harmine derivatives as potent acetylcholinesterase and amyloid beta aggregation dual inhibitors for management of Alzheimer’s disease
por: Du, Hongtao, et al.
Publicado: (2023) -
Bis(triphenylphosphoranylidene)ammonium iodide
por: Beckett, Michael A., et al.
Publicado: (2010) -
Three to Tango: Inhibitory Effect of Quercetin and Apigenin on Acetylcholinesterase, Amyloid-β Aggregation and Acetylcholinesterase-Amyloid Interaction
por: Álvarez-Berbel, Irene, et al.
Publicado: (2022) -
Insights and Ideas Garnered from Marine Metabolites for Development of Dual-Function Acetylcholinesterase and Amyloid-β Aggregation Inhibitors
por: Stoddard, Shana V., et al.
Publicado: (2014) -
Anti-Alzheimer activity of new coumarin-based derivatives targeting acetylcholinesterase inhibition
por: Kamel, Nahla N., et al.
Publicado: (2023)